Your browser doesn't support javascript.
loading
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.
Chan, Emily; McKenney, Jesse K; Hawley, Sarah; Corrigan, Dillon; Auman, Heidi; Newcomb, Lisa F; Boyer, Hilary D; Carroll, Peter R; Cooperberg, Matthew R; Klein, Eric; Fazli, Ladan; Gleave, Martin E; Hurtado-Coll, Antonio; Simko, Jeffry P; Nelson, Peter S; Thompson, Ian M; Tretiakova, Maria S; Troyer, Dean; True, Lawrence D; Vakar-Lopez, Funda; Lin, Daniel W; Brooks, James D; Feng, Ziding; Nguyen, Jane K.
Afiliação
  • Chan E; Department of Pathology, University of California San Francisco (UCSF), San Francisco, CA, USA. Emily.Chan@ucsf.edu.
  • McKenney JK; Robert J. Tomsich Institute of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Hawley S; Canary Foundation, Palo Alto, CA, USA.
  • Corrigan D; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Auman H; Canary Foundation, Palo Alto, CA, USA.
  • Newcomb LF; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Boyer HD; University of Washington Medical Center, Seattle, WA, USA.
  • Carroll PR; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Cooperberg MR; Department of Urology, University of California San Francisco (UCSF), San Francisco, CA, USA.
  • Klein E; Department of Urology, University of California San Francisco (UCSF), San Francisco, CA, USA.
  • Fazli L; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Gleave ME; University of British Columbia, Vancouver, BC, Canada.
  • Hurtado-Coll A; University of British Columbia, Vancouver, BC, Canada.
  • Simko JP; University of British Columbia, Vancouver, BC, Canada.
  • Nelson PS; Department of Pathology, University of California San Francisco (UCSF), San Francisco, CA, USA.
  • Thompson IM; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Tretiakova MS; University of Washington Medical Center, Seattle, WA, USA.
  • Troyer D; CHRISTUS Medical Center Hospital, San Antonio, TX, USA.
  • True LD; University of Washington Medical Center, Seattle, WA, USA.
  • Vakar-Lopez F; Eastern Virginia Medical School, Norfolk, VA, USA.
  • Lin DW; Department of Pathology, UT Health, San Antonio, TX, USA.
  • Brooks JD; University of Washington Medical Center, Seattle, WA, USA.
  • Feng Z; University of Washington Medical Center, Seattle, WA, USA.
  • Nguyen JK; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Mod Pathol ; 35(8): 1092-1100, 2022 08.
Article em En | MEDLINE | ID: mdl-35145197

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article